FreeThink Technologies

FreeThink Technologies

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $8M

Overview

FreeThink Technologies, founded in 2007 and headquartered in Easton, Connecticut, is a specialized service and software provider focused on pharmaceutical stability and formulation. Its core offering is the ASAPprime® software platform for accelerated stability studies, complemented by a full-service analytical laboratory for formulation development and stability testing. The company serves a global clientele, positioning itself as a critical partner in de-risking and accelerating drug development through predictive science. It is a privately held, revenue-generating business built on a services and platform model.

DiagnosticsDrug Delivery

Technology Platform

ASAPprime® software for accelerated stability prediction and modeling, integrated with material-sparing experimental design and analysis.

Funding History

1
Total raised:$8M
Series A$8M

Opportunities

Growing demand for accelerated drug development and the expansion of complex biologics create a larger market for predictive stability services.
The SaaS model for ASAPprime® offers scalable, high-margin growth as it becomes an industry-standard tool.
Geographic expansion and offering new service modules (e.g., advanced extractables & leachables, nitrosamine risk assessment) present additional revenue streams.

Risk Factors

Revenue is dependent on pharmaceutical R&D budgets, which can be cyclical.
Technological disruption from competitors or regulatory shifts in stability guidelines could challenge the core ASAP methodology.
As a private company, access to growth capital may be limited compared to well-funded rivals.

Competitive Landscape

FreeThink competes with large, full-service CROs (like Charles River, Labcorp, PPD) that offer stability testing, but differentiates with its specialized ASAP expertise and proprietary software. It also faces competition from other niche stability consulting firms and software providers focused on predictive stability, though its integrated lab-software model and scientific reputation provide a strong market position.